KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Debt to Equity (2019 - 2025)

Evolent Health (EVH) has 10 years of Debt to Equity data on record, last reported at $1.26 in Q3 2025.

  • For Q3 2025, Debt to Equity rose 117.98% year-over-year to $1.26; the TTM value through Sep 2025 reached $1.26, up 117.98%, while the annual FY2024 figure was $0.66, 18.23% up from the prior year.
  • Debt to Equity reached $1.26 in Q3 2025 per EVH's latest filing, up from $0.92 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.26 in Q3 2025 and bottomed at $0.31 in Q4 2021.
  • Average Debt to Equity over 5 years is $0.58, with a median of $0.56 recorded in 2023.
  • Peak YoY movement for Debt to Equity: soared 163.19% in 2021, then fell 1.87% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $0.31 in 2021, then surged by 54.55% to $0.48 in 2022, then increased by 16.37% to $0.56 in 2023, then increased by 18.23% to $0.66 in 2024, then skyrocketed by 90.35% to $1.26 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt to Equity were $1.26 in Q3 2025, $0.92 in Q2 2025, and $0.88 in Q1 2025.